نتائج البحث

1

PH-0656 Prediction of toxicity after prostate cancer RT: the value of a SNP-interaction polygenic risk score

المصدر: Radiotherapy and Oncology. 161:S526-S528

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, medicine.disease, Prostate cancer, Internal medicine, Toxicity, medicine, SNP, Radiology, Nuclear Medicine and imaging, Polygenic risk score, business, Value (mathematics)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4bbc68083fbec2187c1f7672328f6f9aTest
https://doi.org/10.1016/s0167-8140Test(21)07388-6

2

PD-0766 Impact of treatment and clinical factors on worsening of functional scales after prostate cancer RT

المؤلفون: Riccardo Valdagni, Alessandro Cicchetti, A. Webb, M. Lambrecht, Ana Vega, Liv Veldeman, Dirk De Ruysscher, Catharine M L West, Nuradh Joseph, Christopher J. Talbot, Jenny Chang-Claude, Elena Sperk, Rebecca Elliott, Tiziana Rancati, Petra Seibold, Barbara Avuzzi, Ananya Choudhury, D. Azria

المصدر: Radiotherapy and Oncology. 161:S596-S598

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Prostate cancer, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1e0d59d7b5b24cb27a41934135ce736bTest
https://doi.org/10.1016/s0167-8140Test(21)07045-6

3

PD-0925 An European cross-cultural analysis of worsening of functional scales in prostate cancer patients after RT

المؤلفون: A. Webb, Barbara Avuzzi, Riccardo Valdagni, Ananya Choudhury, Jenny Chang-Claude, Tiziana Rancati, Liv Veldeman, M. Lambrecht, Ana Vega, David Azria, Elena Sperk, Christopher J. Talbot, Petra Seibold, Alessandro Cicchetti, Catharine M L West, Dirk De Ruysscher, Nuradh Joseph, Rebecca Elliott

المصدر: Radiotherapy and Oncology. 161:S765-S767

مصطلحات موضوعية: Oncology, Prostate cancer, medicine.medical_specialty, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, medicine.disease, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::82cbaf0c82851609c6d378c4e11a24b1Test
https://doi.org/10.1016/s0167-8140Test(21)07204-2

4

Metabolic Changes in Children that Received Chemotherapy

المؤلفون: Elena Soto-Vega, Juan C. Vázquez, María José Muñoz-Pérez, María de la Concepción Pérez de Celis Herrero, Luis S. Carrillo-Vicente

المصدر: Journal of Pediatric Hematology/Oncology. 41:448-451

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b942a4977dc163e3ba254781dbff3dTest
https://doi.org/10.1097/mph.0000000000001401Test

5

CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL

المؤلفون: Anita Deswal, Chelsea C. Pinnix, Kaveh Karimzad, Sattva S. Neelapu, Paolo Strati, Michael Wang, Sairah Ahmed, Catherine M. Claussen, Melody R. Becnel, Efstratios Koutroumpakis, R. Steiner, Elizabeth J. Shpall, Nicolas Palaskas, Li Feng, Jason R. Westin, Francisco Vega, Cristina Gutierrez, Jose Banchs, L. J. Nastoupil

المصدر: Hematological Oncology. 39

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Standard of care, Adult patients, business.industry, Hematology, General Medicine, medicine.disease, Internal medicine, medicine, business, B-cell lymphoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::094edceec064fbb6130a5888fbb70779Test
https://doi.org/10.1002/hon.177_2880Test

6

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

المؤلفون: A. Webb, David Azria, Sarah L. Kerns, Karen Foweraker, Ana Carballo, Barbara Avuzzi, Luis Aznar-Garcia, Roxana Draghici, Monica Ramos, Stéphanie Peeters, Benjamin Gauter-Fleckenstein, Daniel S. Higginson, Anna Maria Paganoni, Ulrich Giesche, Monika Kaushik, Corinne Faivre-Finn, Ananya Choudhury, Andrea Manzoni, Jörg Schäfer, Carsten Herskind, Frances Kenny, Paolo Zunino, Valérie Fonteyne, Abigail Pascoe, S. Morlino, Paloma Sosa-Fajardo, Manjusha Keni, Karin Haustermans, A. Giraldo, Jaroslaw Krupa, Claudia Sangalli, Thomas Schnabel, Gert De Meerleer, Yolande Lievens, Patricia Calvo-Crespo, Marie-Pierre Farcy-Jacquet, Petra Seibold, Nicola Rares Franco, Ramón Lobato-Busto, Irene Fajardo-Paneque, Tim Rattay, Ana Vega, Riccardo Valdagni, Elena Delmastro, Irmgard Helmbold, Ben G. L. Vanneste, Richard G. Stock, Donna Appleton, Debbie Payne, Barry S. Rosenstein, Liv Veldeman, Rebecca Elliott, Tiziana Rancati, Alison M. Dunning, Claire P. Esler, Sridhar Thiagarajan, Elisabetta Garibaldi, Muriel Brengues, Michela Carlotta Massi, Simon Pilgrim, Maria C. De Santis, Wilfried De Neve, Miguel E. Aguado-Barrera, Evert J. Van Limbergen, Olivia-Fuentes-Rios, Paul Symonds, Jenny Chang-Claude, Elena Sperk, Catharine M L West, Petra Stegmaier, Antonio Gómez-Caamaño, Marzia Franceschini, Laura Torrado Moya, Simon Wright, Kufre Sampson, Kalliope Valassiadou, Francesca Ieva, Burkhard Neu, Isabel Dominguez-Rios, Francoise Bons, Marie-Luise Sautter-Bihl, Gilles Defraene, Tommaso Giandini, Meritxel Molla, Sheryl Green, Victoria Harrop, Alessandro Cicchetti, Christian Weiß, Caroline Weltens, Gabriele Pietro, Christopher Kent, Michael Ehmann, Paula Peleteiro, Dirk De Ruysscher, Thomas Blaschke, Ion Bioangiu, Hazem Khout, Samuel Lavers, Ahmed Osman, Laura Fachal, Subramaniam Vasanthan, Marc van Eijkeren, Laura Lozza, Céline Bourgier, Kelly Lambert, Johannes Claßen, Piet Ost, Kerstie Johnson, Christian Weißenberger, Bibiana Piqué-Leiva, Timothy H Ward, Christel Monten, Maarten Lambrecht, Marlon R. Veldwijk, Erik van Limberghen, Kiran Kancherla, Christopher J. Talbot, Barbara Noris Chiorda, Erik Briers, Sheila Shokuhi

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie

المصدر: RADIOTHERAPY AND ONCOLOGY
Radiotherapy and Oncology, 159, 241-248. Elsevier Ireland Ltd

مصطلحات موضوعية: Male, medicine.medical_specialty, Urinary system, Single-nucleotide polymorphism, Logistic regression, Polymorphism, Single Nucleotide, Nuclear Medicine and imaging, Gastroenterology, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Risk Factors, Internal medicine, Medicine and Health Sciences, medicine, Humans, Nocturia, Radiology, Nuclear Medicine and imaging, Radiation Injuries, Science & Technology, Receiver operating characteristic, Radiotherapy, business.industry, Radiology, Nuclear Medicine & Medical Imaging, Prostatic Neoplasms, Hematology, medicine.disease, Oncology, Area Under Curve, 030220 oncology & carcinogenesis, Toxicity, Cohort, REQUITE, Epistasis, Genetic risk factors, medicine.symptom, Radiology, business, Late toxicity, Life Sciences & Biomedicine, SNPs

وصف الملف: Print-Electronic; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a7b893793cb9be0c1758ad6b546648Test
https://lirias.kuleuven.be/handle/20.500.12942/691375Test

7

45 GyRBE for group III orbital embryonal rhabdomyosarcoma

المؤلفون: Raymond B. Mailhot Vega, Marinka L.F. Hol, Haruka Uezono, Vibhuti Agarwal, Scott Bradfield, Ronny L. Rotondo, Daniel J. Indelicato, Julie A. Bradley

المساهمون: Academic Medical Center

المصدر: Acta oncologica (Stockholm, Sweden), 58(10), 1404-1409. Informa Healthcare

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Cog, Internal medicine, Proton Therapy, medicine, Humans, Rhabdomyosarcoma, Embryonal, Radiology, Nuclear Medicine and imaging, Ifosfamide, Prospective Studies, Progression-free survival, Child, Rhabdomyosarcoma, Prospective cohort study, Antineoplastic Agents, Alkylating, Cyclophosphamide, business.industry, Radiotherapy Planning, Computer-Assisted, Head and neck tumors, Follow up studies, Infant, Dose-Response Relationship, Radiation, Hematology, General Medicine, medicine.disease, Neoadjuvant Therapy, Progression-Free Survival, Tumor Burden, Radiation therapy, Child, Preschool, 030220 oncology & carcinogenesis, Orbital Neoplasms, Female, Embryonal rhabdomyosarcoma, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d90249bd6e808271ddd1f7e4b07130Test
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073765054&origin=inwardTest

8

1667TiP Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study

المؤلفون: V. Gutierrez Calderon, J.L. Firvida Perez, M.P. Diz Tain, R. Alvarez Cabellos, A.L. Moreno Vega, M.R. Garcia Campelo, Luis León-Mateos, Edurne Arriola, Luis Paz-Ares, L. Baez, A. Sanchez Hernandez, J.M. Oramas Rodriguez, Margarita Majem, C. Aguado de la Rosa, Á. Callejo Mellén, J.L. Marti Ciriquian, V. Amezcua, M.C. Marti Blanco, Dolores Isla

المصدر: Annals of Oncology. 32:S1171-S1172

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Durvalumab, business.industry, chemistry.chemical_element, Hematology, First line treatment, chemistry, Internal medicine, medicine, business, Platinum, Extensive-stage small cell lung cancer, Etoposide, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::74f9d432fa19553c922e186a8d7a75e2Test
https://doi.org/10.1016/j.annonc.2021.08.251Test

9

1724P Prognostic parameters at admission as predictors of hospital length of stay (HLOS) and overall survival (OS) in hospitalized oncologic patients (pts) of a tertiary hospital

المصدر: Annals of Oncology. 32:S1195-S1196

مصطلحات موضوعية: medicine.medical_specialty, Oncology, business.industry, Internal medicine, medicine, Overall survival, Length of hospitalization, Hematology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::15647de44ce7ab0da866b5bc85d746bdTest
https://doi.org/10.1016/j.annonc.2021.08.1696Test

10

Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib

المؤلفون: Linghua Wang, Rashmi Kanagal-Shamanna, Shaojun Zhang, Lucy Navsaria, Chi Young Ok, Guilin Tang, C. Cameron Yin, Preetesh Jain, Hun Ju Lee, Francisco Vega, Loretta J. Nastoupil, Shaoying Li, Ranjit Nair, Maria Badillo, Christopher R. Flowers, Michael L. Wang, Keyur M. Patel

المصدر: American journal of hematologyREFERENCES. 96(5)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d9eef9b12c3f4add2e75f5065fe3f3Test
https://pubmed.ncbi.nlm.nih.gov/33491779Test

تنقيح النتائج